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Rabies virus (RABV) is a pathogen well adapted to the
mammalian nervous system (NS) where it infects the neu-
rons, causing an acute myelo-encephalitis fatal in most
mammalian species, and humans in particular. RABV is
transmitted by saliva of an infected animal through bites
or scratches or by unfortunate transplantation of organs
originated from unsuspected rabid donors. RABV enters
the NS via a motor neuron through the neuromuscular
junction (NMJ), or a sensory nerve through nerve spin-
dles. It then travels from one neuron to the next, along the
spinal cord to the brain and the salivary glands where vir-
ions are excreted in the saliva. The envelope G protein
trimer is responsible for the attachment of the virus to tar-
get cells and enable the virus to be transported to the NS
via the retrograde pathway. There is convincing evidence
that the muscular form of the nicotinic acetylcholine
receptor (nAChR), the neuronal cell adhesion molecule
(NCAM) and the p75 neurotrophin receptor (p75NTR)
bind RABV and/or facilitate RABV entry into cells. Other
components of the cell membrane, such as gangliosides,
may also participate in the entry of RABV. According to
the localization of the three molecules, their role in entry
and propagation of the virus could be as follows: RABV
particles from saliva are transferred by bites to the vicinity
of NMJs and sensory terminations. At the NMJs, free RABV
particles bind to nAChR located on the top of junctional
folds, in area where nerves and muscles are in close con-
tact. This concentrates virus particles in front of the NMJs
and improves the probability of RABV being taken up by
the nerve terminal. RABV particles bind to NCAM present
at the presynaptic membrane. The presence of ganglio-
sides in this membrane concentrates NCAM into "lipid
raft" microdomains, thereby allowing the simultaneous
binding of G proteins and improving the membrane
fusion process or allowing the detachment of RABV from
nAChR. After crossing the NMJ, RABV is internalised by
neutral and acidic vesicles, which may trigger the fusion of
the virus envelope and the release of nucleocapsids. Alter-
natively, intact RABV remain in vesicles and travel along
the nerve endings to the neuronal soma where replication
can occur. Possibly in sensory endings or at subsequent
steps of the RABV journey, but probably not at the NMJs
where P75NTR is not detected, the binding of RABV to
p75NTR may enable RABV to follow caveolae transcytosis,
allowing the axonal retrograde transport of RABV parti-
cles.
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